CClinicalTrials.gg
CompletedNCT00001664Updated Jul 2, 2017

Sleep Disorders of Patients With Diseases of the Nervous System

An observational study in Hypersomnia, Narcolepsy and Nervous System Disease, sponsored by National Institute of Neurological Disorders and Stroke (NINDS). Completed at 1 site in United States. Open to participants aged 5 Years and older. Per ClinicalTrials.gov, last updated 2017-07-02.

Sponsored by National Institute of Neurological Disorders and Stroke (NINDS) · Observational

Study type
Observational
Enrollment
83
Ages
5 Years and older
Sex
All
01

Study summary

The purpose of this study is to assist training doctors about different diseases of the nervous system affecting sleep.

Patients selected to participate in this study will have any of a variety of sleep disorders. They will undergo several tests including an overnight recording of brain activity, eye movement, leg movement, breathing, heart rate, and other measures.

Results of these tests will be used to better understand diseases causing sleep disorders and may be used to develop better treatments for them.

Read the detailed description

The objective of this protocol is to provide training in a broad range of neurological sleep disorders to clinical associates who are eligible for sitting in the Board examination of the Added Qualification of Clinical Neurophysiology administered by the American Board of Psychiatry and Neurology. This protocol is to supplement small accrual of research patients who are referred from within the NIH.

02

Conditions studied

  • Hypersomnia
  • Narcolepsy
  • Nervous System Disease
  • Sleep Disorder

Keywords

  • Narcolepsy
  • Polysomnography
  • Multiple Sleep Latency Test
  • Sleep Disorders
  • Hypersomnia
  • Periodic Leg Movements
03

In context

Sleep Wake Disorders

788 studies on the registry are indexed under Sleep Wake Disorders; 186 are open to participants now.

This study's enrollment of 83 is below the median of 114 across 215 observational studies indexed under Sleep Wake Disorders.

Browse Sleep Wake Disorders studies →

Lead sponsor

National Institute of Neurological Disorders and Stroke (NINDS) is the lead sponsor of 592 studies on the registry; 56 are open to participants now.

Of its 18 completed or terminated interventional studies of FDA-regulated products, 8 (44%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
5 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

  • IINCLUSION CRITERIA:

Patients 5 years of age and older, with the following referring diagnoses:

Narcolepsy

Hypersomnia

REM behavior disorder

Frontal nocturnal dystonia

Restless legs syndrome

Insomnia

Parasomnia

Nocturnal epileptic seizure

Nocturnal movement disorder

Sleep-related diagnostic dilemma

Sleep apnea associated with neurological disorders

Patients who are ambulatory and who are able to comply with the study procedures.

Patients who are able to understand and sign the informed consent. (Parent or guardian for minors).

EXCLUSION CRITERIA:

Patients who have been diagnosed with acute and progressive neurological disorders.

Patients who are unable to comply with the study procedures and require other than standard care.

05

Study design

Enrollment
83 participants (actual)
06

Study locations

1 site
  • National Institutes of Health Clinical Center, 9000 Rockville Pike
    Bethesda, Maryland 20892, United States
07

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 2, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
08

Registry details

Key details

Study ID
NCT00001664
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
First posted
Nov 4, 1999
Start date
Dec 4, 1996
Completion
Sep 7, 2011
Last update
Jul 2, 2017
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion